Non-bacterial thrombotic endocarditis classification: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
{{CMG}}; {{AE}}{{Aisha}}
{{CMG}}; {{AE}}{{Aisha}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==

Revision as of 08:19, 20 July 2020

non-bacterial thrombotic endocarditis

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating non-bacterial thrombotic endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-bacterial thrombotic endocarditis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-bacterial thrombotic endocarditis classification

CDC on Non-bacterial thrombotic endocarditis classification

Non-bacterial thrombotic endocarditis classification in the news

Blogs on Non-bacterial thrombotic endocarditis classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Non-bacterial thrombotic endocarditis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

Classification

According to Allen and Sirota,[1] [2] Non-bacterial thrombotic endocarditis may be classified according to morphology into 5 subtypes:

Allen and Sirota macroscopic classification of NBTE
Type of NBTE Features
Type 1
  • Small
  • < 3 mm
  • Univerrucal
  • Firmly attached to the valve
Type 2
Type 3
  • Small
  • 1 - 3 mm
  • Multiverrucal
  • Friable
Type 4
  • Large
  • > 3 mm
  • Multiverrucal
  • Friable
Type 5
  • "Healed-type"
  • Similar in consistency to the attached valve

References

  1. Allen AC, Sirota JH (November 1944). "The Morphogenesis and Significance of Degenerative Verrucal Endocardiosis (Terminal Endocarditis, Endocarditis Simplex, Nonbacterial Thrombotic Endocarditis)". Am. J. Pathol. 20 (6): 1025–55. PMC 2033063. PMID 19970792.
  2. Sanjay Asopa, Anish Patel, Omar A. Khan, Rajan Sharma, Sunil K. Ohri, Non-bacterial thrombotic endocarditis, European Journal of Cardio-Thoracic Surgery, Volume 32, Issue 5, November 2007, Pages 696–701, https://doi.org/10.1016/j.ejcts.2007.07.029

Template:WH Template:WS